Atazanavir Sulfate

Product NDC
51407-171
11-digit product format
514070171
Labeler code
51407
Product ID
51407-171_b0a4420a-7458-41b1-e053-2995a90a5f9b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Atazanavir Sulfate
Dosage form
CAPSULE
Route
ORAL
Labeler
Golden State Medical Supply Inc.
Application
ANDA091673
Marketing category
ANDA
Marketing start
2017-12-27
Marketing end
2020-11-30
Substance
ATAZANAVIR SULFATE
Active strength
150 mg/1
Pharmacologic classes
HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51407-171-60EA - Each51407-171a6253014-4b93-4453-890e-b2b85a43686412019-02-13